Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Catalyst Pharmaceuticals, Inc. (CPRX) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$98.51M |
|
$23.27M |
|
$12.52M |
|
$85.99M |
|
$71.38M |
|
$27.13M |
|
$1.96M |
|
$29.09M |
|
$29.09M |
|
$23.27M |
|
$23.27M |
|
$23.27M |
|
$23.27M |
|
$27.13M |
|
$36.56M |
|
116.81M |
|
123.40M |
|
$0.20 |
|
$0.19 |
|
| Balance Sheet Financials | |
$404.60M |
|
$1.31M |
|
$242.07M |
|
$646.68M |
|
$79.57M |
|
-- |
|
$5.70M |
|
$85.26M |
|
$561.41M |
|
$376.71M |
|
$561.41M |
|
118.03M |
|
| Cash Flow Statement Financials | |
$31.93M |
|
$-0.20M |
|
$141.05M |
|
$137.64M |
|
$310.41M |
|
$172.78M |
|
$8.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.09 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
87.29% |
|
27.54% |
|
27.54% |
|
-- |
|
29.53% |
|
23.63% |
|
$31.73M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.63 |
|
1.63 |
|
55.27 |
|
4.15% |
|
6.18% |
|
3.60% |
|
4.15% |
|
$4.76 |
|
$0.26 |
|
$0.26 |
|